Active, Not Recruiting
A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and Previously EB-101 Treated Patients
NCT05725018
- Conditions
- Collagen Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +11 more
- Locations
-
- Stanford University Redwood City, California, United States
- University of Massachusetts Medical School Worcester, Massachusetts, United States